Form 4 holding
10%+ Owner
Scholar Rock Holding Corp
- Security class
- Common Stock
- Shares / value
- 11,259,438
- Estimated value
- $101,166,050
- Report date
- 25 Jul 2024
- Price
- $8.98
- Ownership
- Direct
Siren, L.L.C.
Insider Reports History
- Reporting-owner location
- Greenwich, CT
- Latest reporting-owner signature
-
INVUS GLOBAL MANAGEMENT, LLC, By: /s/ Raymond Debbane, Name: Raymond Debbane, Title: President
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Siren, L.L.C.
Form 4 holding
Director, 10%+ Owner
LEXICON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 35,402,689
- Estimated value
- $92,755,045
- Report date
- 25 Jul 2024
- Price
- $2.62
- Ownership
- Indirect
Form 4 holding
10%+ Owner
GLYCOMIMETICS INC
- Security class
- Common Stock
- Shares / value
- 8,589,064
- Estimated value
- $2,294,139
- Report date
- 25 Jul 2024
- Price
- $0.2671
- Ownership
- Direct
Insider Reports Filed by Siren, L.L.C.
3
SRRK
Scholar Rock Holding Corp
- Report period
- 25 Jul 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 29 Jul 2024, 18:03
- Role
- 10%+ Owner
- Next action
- Open filing details
3
GLYC
GLYCOMIMETICS INC
- Report period
- 25 Jul 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 29 Jul 2024, 17:55
- Role
- 10%+ Owner
- Next action
- Open filing details
3
LXRX
LEXICON PHARMACEUTICALS, INC.
- Report period
- 25 Jul 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 29 Jul 2024, 17:31
- Role
- Director, 10%+ Owner
- Next action
- Open filing details